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Clinical and experimental data suggest that stress contributes to the pathology of epilepsy. We review mechanisms by which stress,
primarily via stress hormones, may exacerbate epilepsy, focusing on the intersection between stress-induced pathways and the
progression of pathological events that occur before, during, and after the onset of epileptogenesis. In addition to this temporal
nuance, we discuss other complexities in stress-epilepsy interactions, including the role of blood-brain barrier dysfunction,
neuron-glia interactions, and inﬂammatory/cytokine pathways that may be protective or damaging depending on context. We
advocate the use of global analytical tools, such as microarray, in support of a shift away from a narrow focus on seizures and
towards proﬁling the complex, early process of epileptogenesis, in which multiple pathways may interact to dictate the ultimate
onset of chronic, recurring seizures.
1.Introduction
In clinical studies of epilepsy patients, stress is the most fre-
quently self-reported trigger of seizures—higher than other
precipitants such as sleep deprivation, fatigue, diet, or even
missed medication [1–3]. In prospective study, increased
severity of self-reported stress/anxiety also correlates with
increased risk of subsequent seizure [4]. These studies,
derived from the ﬁrst-hand experience of those who suﬀer
from epilepsy, set the stage for a wealth of experimental data
indicating that stress may impact and exacerbate epilepsy
in at least four contexts: (1) life stress, particularly early
life stress, may create a vulnerability for the incidence of
epilepsy; (2) stress may play a role in the etiology of
symptomatic epilepsy by exacerbating the causal event, such
as traumatic brain injury, stroke, or status epilepticus; (3)
stress may play a role in the process of epileptogenesis—the
“silent period” that follows initial injury and is characterized
by progressive cellular and network changes thought to
underlie the ultimate onset of chronic seizures; (4) stress
may increase the frequency or severity of seizures after
epilepsy onset. In this paper, we focus on the molecular
pathways by which stress and epilepsy may converge. We
emphasize the nuance and complexity of these pathways,
noting that the role of particular molecules can vary from
neuroprotective to destructive, depending on context. To
highlight this complexity, we discuss the signaling pathways
that are initiated following blood-brain barrier dysfunction
and emphasize neural-glia interactions. Finally, in light of
the complex interplay of pathways that aﬀect epilepsy, we
advocate strategies for “global” characterization of epilepsy
pathology to complement the single pathway investigation
typically favored by inference-guided experimentation.
2.Mechanismsby WhichStress MayCreate
Vulnerabilityto Epilepsy
In addition to the immediate physiological “stress response,”
stressful incidents, particularly early in life, can cause long-
term changes in the organism that create vulnerability for
a variety of diseases [5, 6]. This concept of stress-induced2 Cardiovascular Psychiatry and Neurology
vulnerability has not been frequently applied to epilepsy,
despite evidence that many persistent changes induced by
stress are likely to aﬀect mechanisms of epilepsy. Perhaps
most importantly, early life stress can cause long-lasting
alterations in the regulation of the hypothalamic-pituitary
adrenal (HPA) axis [7], which controls the release of stress
hormones (glucocorticoids; GCs). These alterations, which
are eﬀected by cognitive mechanisms (neural plasticity in
reinforcing stress-responsive networks [8, 9]) and genetic
transcriptional mechanisms (classical and epigenetic regu-
lation of genes controlling the HPA axis [10, 11]), lead
to adult animals that have an impaired stress response to
aversive stimuli, including increase in stress hormone release
and impairment of HPA negative feedback [12]. Thus, all
aspects of the stress response that may directly exacerbate
epilepsy (described in subsequent sections) are likely to
be particularly potent in individuals that have experienced
early life stress. For example, early life stress aﬀects adult
induction of immune and inﬂammatory pathways [13, 14],
which have been implicated in neural damage in epilepsy.
Similarly, early life stress decreases the expression of brain-
derived neurotrophic factor (BDNF) in the adult brain [15–
17], which is a critical mediator of neuroprotection across
epilepsy models.
Early life stress may also have a profound impact on
the development of white matter in the brain. Preliminary
work in our lab and others indicates that stress may
increase or decrease myelination, depending on develop-
mental stage and other unknown factors (unpublished data
and [18]). These paradoxical ﬁndings are echoed by the
literature showing that GCs induce in vitro oligodendrocyte
precursor cells (OPCs) to diﬀerentiate into mature oligo-
dendrocytes [19–21] and promote oligodendrocyte survival
[22], yet total removal of GCs by adrenalectomy results in
hypermyelination [23] while prenatal GC treatment delays
myelination in sheep [24]. If early life stress does result
in delayed and/or hypomyelination, it would constitute a
startling and underappreciated similarity to a variety of
seizure syndromes. Delayed myelination is a hallmark of
infantile spasms [25] and other seizure disorders [26], and
several genetic hypomyelination disorders or manipulations
include severe seizure symptoms [27, 28]. In these models,
treatment is associated with white matter recovery: amino
acid supplement of patients with a serine biosynthesis
disorder resulted in restoration of white matter and major
seizurereduction[29,30].Pharmacologically(L-allylglycine,
bicuculline, and kainic acid) or electrically induced seizures
also cause demyelination [31, 32], and alterations of white
matter have been associated with both symptomatic and
idiopathic epilepsy [33–35] and with hippocampal sclerosis
[36]. Indeed, while glia have received a surge of recent
interest for causal roles in epilepsy, this attention has
focused almost exclusively on astrocytes. Possible roles for
oligodendrocytes remain largely uninvestigated.
Direct investigation of early life stress on subsequent
epilepsy is sparse, but there have been at least a few
studies in rodents. One study subjected pups to maternal
separation (MS) or normal rearing and then induced status
epilepticus (SE) by lithium-pilocarpine at P16 and assessed
subsequent advent of behavioral seizures in adulthood.
Only one normally reared rat showed adult spontaneous
recurrent seizures (SRS), whereas all 8 rats from the MS
group developed SRS [37], though it is not clear if this
diﬀerence can be attributed to a persistent “vulnerability”
created by MS or to a more immediate eﬀect of the MS
stress on severity of induced SE. Another group subjected
rats to MS or mild handling and assessed seizure induction
by amygdala kindling subsequently in adulthood. MS rats
required signiﬁcantly less stimulation for seizure induction
[38]. Gendered analysis indicates that this eﬀect may only
hold true for female rats [39]—an interesting ﬁnding given
the well-known eﬀects of sex hormones both on stress
response and on epilepsy [9, 40–42]. A similar study showed
that chronic GC supplement in adult adrenalectomized rats
alsoacceleratedtherateofamygdalakindling[43],indicating
that interactions between GCs and seizure threshold may be
generalized outside of the early life period.
The limited available direct evidence, as well as general
observations of persistent changes mediated by early life
stress, indicates that it could cause a life-long vulnerability
for subsequent epilepsy. Given that the factors that govern
whether or not epileptogenesis occurs after traumatic injury
are poorly understood, the role of early life stress vulnerabil-
ity deserves more in-depth study.
3. Mechanisms by Which Stress May Exacerbate
EtiologicalIncidents
The most common form of symptomatic epilepsy involves
a precipitating traumatic incident—an initial prolonged
seizure (SE), stroke, traumatic brain injury, or infection/
fever—that is followed by onset of epilepsy after a delay
of months to years. A wealth of evidence indicates that
damage suﬀered during such incidents and possibly also
the induction of repair mechanisms constitute the ﬁrst
steps of epileptogenesis. Can activation of stress pathways
during etiological incidents exacerbate damage or otherwise
contribute to the proximate steps of epileptogenesis?
One of the common occurrences across diﬀerent types of
precipitating incidents is immediate neurological injury and
cell death. GCs exacerbate such neural injury. For example,
viralvectorblockadeofglucocorticoidreceptors(GR)during
kainicacid(KA)treatment(usedtoinduceSEandassociated
excitotoxic cell death) signiﬁcantly reduced the size of the
ensuing hippocampal lesion and also signiﬁcantly reduced
c e l ld e a t hi nK A - t r e a t e dn e u r a lc e l lc u l t u r ec o t r e a t e dw i t h
GCs [44]. The damaging eﬀe c t so fG C sa p p e a rt ob ea t
least partially dependent on their downregulation of BDNF,
as exogenous BDNF also attenuates the in vitro cell death.
GC induction of proinﬂammatory pathways (discussed in
Section4)alsoplaysamajorrolebyleadingtoexcitotoxiccell
death [45]. Similarly, stress treatment prior to stroke (via the
middle cerebral artery occlusion model) increases levels of
pro-inﬂammatory TNF-α and Il-1β, causing more extensive
cell death in the infarct [46, 47]
Breakdown of the blood-brain barrier (BBB) is also
common across etiological incidents. Research in our lab
and in our collaborator’s has shown that BBB disruptionCardiovascular Psychiatry and Neurology 3
allows serum albumin to enter the brain and activate the
transforming growth factor beta receptor (TGF-βR) signal-
ing pathway in astrocytes, ultimately inducing epileptiform
activity and spontaneous seizures. Blockade of the TGF-βR
prevents albumin-induced signaling, epileptiform activity,
and reduces seizures detected by EEG monitoring ([48–50]
and unpublished data). Interestingly, stress also disrupts the
BBB [51–53] and thus may directly contribute to postinjury
BBBleakiness,likelythroughinductionofpro-inﬂammatory
pathways [54].
4. Mechanisms by Which Stress May Contribute
to Epileptogenesis
Beyond the proximate precipitating incident, the process of
epileptogenesis occurs over a period of weeks to years and is
marked by a somewhat stereotypical progression of restruc-
turing events that precede the onset of chronic spontaneous
seizures [55, 56]. The role of astrocytes in this process has
come to be one of the most studied frontiers in epilepsy
research, due to the eﬀects of activated astrocytes and
gliosis on regulating excitability via extracellular ions and
neurotransmitters, and to the association of glial scars with
hippocampal sclerosis [57, 58]. Pro-inﬂammatory cytokine
pathways are common mediators of astrocyte activation
and epileptogenesis across epilepsy models. For example,
albumin activation of the TGF-β pathway in astrocytes leads
totheinductionofpro-inﬂammatoryandcytokinepathways
including NF-κB[ 48]. Similarly, pilocarpine-induced SE
causes an increase in leukocyte adhesion molecules and
local leukocyte recruitment, a critical ﬁrst step in the
induction of the pro-inﬂammatory immune response [59].
Inbothcases,blockadeofthisinitialpro-inﬂammatoryevent
preventssubsequentonsetofepilepticactivity.WhileGCsare
generally thought of as anti-inﬂammatory, and indeed often
used as therapeutic peripheral anti-inﬂammatory agents,
they actually have pro-inﬂammatory roles within brain [60].
Indeed,stressincreasestheexpressionoractivityofanumber
of mediators of inﬂammation in the brain, including NF-κB,
TNF-α,I L - 1 α,I L - 1 β, prostaglandins, and free radicals such
asNO[45,61–63]viabothcatecholaminesandGCs[60,64].
Thus,stresswouldbeexpectedtoenhancepro-inﬂammatory
pathways that are major aspects of epileptogenesis.
Aberrant neurogenesis in the hippocampus is also a
hallmark of epileptogenesis [65, 66], including the ectopic
migration of new neurons into the hilus. Stress and GCs
inﬂuence the proliferation, diﬀerentiation, and survival of
neural stem cells in the hippocampus [67–69]. Generally,
stress decreases neurogenesis at both proliferation and
survival stages [69], but also decreases the percentage of pre-
cursor cells that adopt a neural cell fate (unpublished data).
It is unknown how or if stress eﬀects on neurogenesis may
interact with aberrant neurogenesis during epileptogenesis.
5. Mechanisms by Which Stress May Exacerbate
the Frequency or Severity of Seizures
After the progression of epileptogenesis and the onset of
epilepsy, patients experience spontaneous recurrent seizures
that vary in frequency and severity. As mentioned in
the introduction of this paper, stress is the major self-
reported precipitant aﬀecting seizure frequency. In support
of these clinical studies, stress pathways have been shown
to promote neural activity in a variety of ways, suggesting
that stress may directly contribute to the hyperexcitability
that causes spontaneous seizures. Corticotropin-releasing
hormone (CRH)—which is released in the brain as the ﬁrst
step of the stress hormone response—causes an increase in
neural discharge and modulates glutamatergic transmission
[70–72]. While CRH acts directly on a variety of neural
receptors [71, 73], it also ultimately induces release of GCs
from the adrenal glands. GCs themselves increase the release
of excitatory glutamate [74], while stress paradigms similarly
induce an increase in extracellular glutamate and aspartate
[75]. Excitatory actions of GCs can be mediated by fast-
acting protein mechanisms [76–78] as well as the classical
delayed (transcriptional) eﬀects of GR, which have been
shown to modulate calcium currents in particular [79, 80].
6. Complexity inEpileptogenicPathwaysand
ExperimentalImplications
We see from the above that stress pathways converge with a
variety of other signaling pathways associated with epilepsy,
including regulators of excitotoxic cell death, myelination,
inﬂammation, astrocytic activation, and neurogenesis. The
nature of this interaction depends on the timing of stress
relative to the progression of epilepsy. However, a variety
of other variable factors make these pathway interactions
quite complex. Firstly, it should be noted that many
eventsassociatedwithepileptogenesis,suchasinﬂammation,
gliosis, and neurogenesis, are frequently assumed to be
pathological. Equally plausible in many cases is that these
pathways may represent (failed) attempts of neuroprotection
and recovery. Stress itself is often conceptualized as having
an “inverted U-shaped” eﬀe c to nagi v e nt a s ko ro u t p u t ,wi t h
extremely low or high amounts of GCs being “detrimental”
but moderate amounts being “beneﬁcial.” Furthermore, it
is widely recognized that the eﬀects of stress may vary
depending on task or context. For example, early life stress
is detrimental by many metrics, but may also lead to a
blunting of inﬂammatory response that is protective in
terms of epilepsy vulnerability [60]. This type of nuanced
analysis must be applied when considering the eﬀect of stress
on epilepsy (protective and detrimental eﬀects of stress on
epilepsy are reviewed in depth by [81]); it would also be well
applied to epileptic pathways in themselves. Inﬂammation,
reactive astrocytes, and neurogenesis in particular have
been alternately described as protective or pathological. The
speciﬁc eﬀects of these mechanisms may vary depending
on severity of injury (i.e., protective after mild precipitating
brain trauma, but overexpressed and damaging after severe
brain injury) or on the speciﬁc stage of epileptogenesis.
Similarly, it is important to consider that most of
these mechanisms are investigated in the context of “strong
inference” type experimentation, wherein a speciﬁc pathway
is genetically or pharmacologically manipulated, and speciﬁc4 Cardiovascular Psychiatry and Neurology
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Figure 1: Transcriptional analysis of GC-responsive genes that are modulated by albumin treatment. Arrays from three animals that were
sacriﬁced 24 hours after albumin treatment [48] were reanalyzed to identify genes that are modulated by both stress and the model of
albumin-induced epileptogenesis. ∗Genes mentioned in text.Cardiovascular Psychiatry and Neurology 5
outputs such as cell death or seizure onset are interpreted
as markers of pathology. In taking a step back to a more
global view of epilepsy, we emphasize that a large number
of molecular mechanisms are in play at any given moment,
interacting in complex ways. What is the net output, for
example, when pathways known to be neuroprotective, and
others known to cause neural damage, are induced at the
same time?
To address such complexity in epileptogenic mecha-
nisms, we advocate the use of global analytical tools such
as microarrays. While microarrays are frequently used as
a discovery tool, they may also be used in a much more
targeted fashion to characterize global events surrounding
a speciﬁc mechanism. For example, we used microarrays to
characterize the transcriptional proﬁle that follows albumin
binding to TGF-βRs, showing that this proximal event
triggers a cascade that is highly similar to TGF-β signaling
inducedbytheendogenousligandTGF-β1,includinganum-
ber of pro-inﬂammatory outputs [48]. Such transcriptional
proﬁles are being gathered for a variety of epilepsy models
by the Consortium for Epilepsy Microarray (Raymond
Dingledine, personal communication), and used to deﬁne
the common set of genes that are modulated across diﬀerent
models of epilepsy, as well as clarify interacting mechanisms
and beneﬁcial/detrimental eﬀects. To demonstrate the utility
of this approach, we reanalyzed our previous array data from
rats treated with albumin, focusing on a subset of genes
identiﬁed as “core GC responsive genes” by the Microarray
Consortium (Figure 1). This allowed us to delineate the
numerous transcriptional intersections between stress and
our epilepsy model. Of particular note, in context of the
mechanisms discussed in this paper, is synergistic modula-
tion of pro-inﬂammatory cytokine pathways by both albu-
min treatment and GCs, including chemokine (C-C motif)
ligand 2 (Ccl2), interleukin-6 (Il6), tumor necrosis factor
(Tnf), and interleukin-1 beta (Il1b). We look forward to
future use of these microarray resources, which will elucidate
the common pathways in various types of epileptogenesis
and allow for nuanced analysis of exacerbating risk factors,
such as stress.
7. Conclusions
Stress may create vulnerability to epilepsy prior to etiological
incidents, as well as exacerbate epileptogenesis following
traumatic injury. While potential eﬀects of stress on neural
injury are well understood, the ways in which early life stress
may create vulnerability for epilepsy, particularly in regard
to possible roles for white matter, represent an unknown
f r o n t i e rf o rf u t u r er e s e a r c h .W h i l es e i z u r e sc o n t i n u et ob e
the deﬁning aspect of epilepsy, nuanced and global analysis
of the complex events that occur during epileptogenesis may
oﬀer greater insight into the progression of, and possible
therapeutic interventions against, epilepsy.
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